Analysts at Citigroup Reconfirmed their Sell rating for Safe Bulkers (SB). The Target Given is $1.25; ABATTIS BIOCEUTICALS ORDINARY SHAR (ATTBF) Sellers Increased By 2158.9% Their Shorts  Standard RecorderSafe Bulkers (NYSE:SB) RatingNew York: In a research report revealed to clients on Wednesday morning, Citigroup maintained their Sell rating on shares...

What Do the Pivots Indicate Regarding Shares of Abattis Bioceuticals (ATTBF)?  Parker City NewsOne of the technical analysis indicators used to glean the overall trend of the market over differing time periods are pivot points. The pivot point itself is where the ...

2158.9% More ABATTIS BIOCEUTICALS CORP ORDINARY SHAR (OTCMKTS:ATTBF) Shorted Shares  K ReviewerABATTIS BIOCEUTICALS CORP ORDINARY SHAR (OTCMKTS:ATTBF) had an increase of its shares shorted by 2158.9%. FINRA issued in February ATTBF's ...

ABATTIS BIOCEUTICALS CORP ORDINARY SHAR (OTCMKTS:ATTBF) Sellers Strengthened By 2158.9% Their Shorts  The EN BulletinABATTIS BIOCEUTICALS CORP ORDINARY SHAR (OTCMKTS:ATTBF) had an increase of its shorted shares by 2158.9%. FINRA published in February ...

Stock to Keep Your Eyes on: Abattis Bioceuticals Corp. (OTC:ATTBF)  Stock DigestAbattis Bioceuticals Corp. (OTC:ATTBF). Abattis Bioceuticals Corp. (OTC:ATTBF) stock price is settled at $0.049 in recent trading activity. Having a look at the ...

Abattis Provides Update on Trading Halt and Announces Management Conference Call  GlobeNewswireVANCOUVER, British Columbia, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is ...